Petros Pharmaceuticals Inc (NASDAQ:PTPI) traded at $0.04 at close of the session on Monday, April 21 and made an upward move of 2.44% on its previous day’s price.
Looking at the stock we see that its previous close was $0.04 and the beta (5Y monthly) reads 2.09 with the day’s price range being $0.0364 – $0.0424. In terms of its 52-week price range, PTPI has a high of $0.77 and a low of $0.04. The company’s stock has lost about -44.74% over that past 30 days.
Petros Pharmaceuticals Inc has a market cap of $2.24 million and is expected to release its quarterly earnings report on 2024-Nov-12.
On the other hand, looking at the outlook for the PTPI stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -35.45% off its SMA20 and -60.00% from its 50-day simple moving average. The RSI (14) is pointing at 35.10 while the volatility over the past week is 12.58% and jumps to 22.08% over the past one month. The beta value is 2.21, while the average true range (ATR) is currently pointing at 0.02.
Coming back to Petros Pharmaceuticals Inc (NASDAQ:PTPI), we note that the average 3-month trading volume was 35.85 million, while that of the preceding 10-day period stands at 3.66 million. Current shares outstanding are 53.52 million.
The insiders hold 18.16% of the company’s shares while institutions hold 1.82%. The data shows that short shares as of 2025-03-31, stood at 1.48 million at a short ratio of 0.04. This represents a 532.00 short interest in shares outstanding on 2025-03-31. Shares short rose in March from the previous month at 0.35 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -89.34% down in year-to-date price movement.
